In vivo evaluation of [18F]fluoroetanidazole as a new marker for imaging tumour hypoxia with positron emission tomography

Abstract

Development of hypoxia-targeted therapies has stimulated the search for clinically applicable noninvasive markers of tumour hypoxia. Here, we describe the validation of [18F]fluoroetanidazole ([18F]FETA) as a tumour hypoxia marker by positron emission tomography (PET). Cellular transport and retention of [18F]FETA were determined in vitro under air vs… (More)
DOI: 10.1038/sj.bjc.6601862

Topics

9 Figures and Tables

Cite this paper

@article{Barthel2004InVE, title={In vivo evaluation of [18F]fluoroetanidazole as a new marker for imaging tumour hypoxia with positron emission tomography}, author={Helen Barthel and H. Wilson and David R Collingridge and G. Brown and Salih Osman and Soumya Luthra and F. Brady and Patricia Workman and P. M. Price and Eric O. Aboagye}, journal={British Journal of Cancer}, year={2004}, volume={90}, pages={2232 - 2242} }